Search Results - "BORER, J"

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study by Swedberg, Karl, Prof, Komajda, Michel, Prof, Böhm, Michael, Prof, Borer, Jeffrey S, Prof, Ford, Ian, Prof, Dubost-Brama, Ariane, MD, Lerebours, Guy, MD, Tavazzi, Luigi, Prof

“…Summary Background Chronic heart failure is associated with high mortality and morbidity. Raised resting heart rate is a risk factor for adverse outcomes. We…”
Get full text

Ischaemic cardiac events and use of strontium ranelate in postmenopausal osteoporosis: a nested case–control study in the CPRD by Cooper, C., Fox, K. M., Borer, J. S.

“…Summary We explored the cardiac safety of the osteoporosis treatment strontium ranelate in the UK Clinical Practice Research Datalink. While known…”
Get full text

Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: An efficacy and safety analysis of SHIFT study by Tavazzi, L, Swedberg, K, Komajda, M, Böhm, M, Borer, J.S, Lainscak, M, Robertson, M, Ford, I

“…Abstract Background Heart failure (HF) and chronic obstructive pulmonary disease (COPD) frequently coexist, with undefined prognostic and therapeutic…”
Get full text

Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial by Yeomans, N. D., Graham, D. Y., Husni, M. E., Solomon, D. H., Stevens, T., Vargo, J., Wang, Q., Wisniewski, L. M., Wolski, K. E., Borer, J. S., Libby, P., Lincoff, A. M., Lüscher, T. F., Bao, W., Walker, C., Nissen, S. E.

“…Summary Aim To evaluate GI safety of celecoxib compared with 2 nonselective (ns) NSAIDs, as a secondary objective of a large trial examining multiorgan safety…”
Get full text

A single-institution experience of complete primary repair of bladder exstrophy in girls: risk factors for urinary retention by Sack, B.S., Borer, J.G.

“…Historically after complete primary repair of exstrophy (CPRE) in girls, it had been more likely to observe urinary incontinence than retention. Following…”
Get full text

Early urodynamic findings after complete primary repair of exstrophy by Weaver, J.K., Eftekharzdeh, S., Lee, T., Roth, E.B., Venia, A., Kryger, J.V., Groth, T.W., Shukla, A.R., Lee, R., Borer, J.G., Mitchell, M.E., Canning, D.A., Weiss, D.A.

“…Detrusor contraction in bladder exstrophy (BE) patients following reconstruction is poorly understood as there are few published studies assessing urodynamic…”
Get full text

Short-term outcomes of the multi-institutional bladder exstrophy consortium: successes and complications in the first two years of collaboration by Borer, J.G, Vasquez, E, Canning, D.A, Kryger, J.V, Bellows, A, Weiss, D, Groth, T, Shukla, A, Kurtz, M.P, Mitchell, M.E

“…Summary Introduction /background: Bladder exstrophy is a rare diagnosis that presents major reconstructive challenges. To increase experience and proficiency…”
Get full text

Anatomic findings associated with epispadias in boys: Implications for surgical management and urinary continence by Cendron, M., Cho, P.S., Pennison, M., Rosoklija, I., Diamond, D.A., Borer, J.G.

“…Pre-operative physical examination of male epispadias allows for classification of epispadias level as glanular (GE), penile (PE) or penopubic (PPE), and for…”
Get full text

Renal biopsy in congenital ureteropelvic junction obstruction: Evidence for parenchymal maldevelopment by Huang, W-Y, Peters, C.A., Zurakowski, D., Borer, J.G., Diamond, D.A., Bauer, S.B., McLellan, D.L., Rosen, S.

“…The renal histologic changes associated with congenital ureteropelvic junction obstruction (UPJO) and the relationship to clinical imaging have not been well…”
Get full text

Influence of background treatment with mineralocorticoid receptor antagonists on ivabradine's effects in patients with chronic heart failure by Komajda, Michel, Böhm, Michael, Borer, Jeffrey, Ford, Ian, Krum, Henry, Tase, Adrian, Tavazzi, Luigi, Swedberg, Karl

“…Aims A post‐hoc analysis of the SHIFT trial was performed to explore whether ivabradine is beneficial in patients with systolic heart failure, in sinus rhythm,…”
Get full text

Treatment Effects On The Cost Burden Of Hospitalizations In Patients With Chronic Systolic Heart Failure by Kansal, A, Kielhorn, A, Dorman, E, Krotneva, S, Zheng, Y, Patel, H, Borer, J

Get full text

Quantum dot labeling of mesenchymal stem cells by Muller-Borer, Barbara J, Collins, Maria C, Gunst, Philip R, Cascio, Wayne E, Kypson, Alan P

“…Mesenchymal stem cells (MSCs) are multipotent cells with the potential to differentiate into bone, cartilage, fat and muscle cells and are being investigated…”
Get full text

Targeted anticytokine therapy in patients with chronic Heart failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL) by MANN, Douglas L, MCMURRAY, John J. V, KRUM, Henry, LIU, Peter, NIEMINEN, Markku, TAVAZZI, Luigi, VAN VELDHUISEN, Dirk Jan, WALDENSTROM, Anders, WARREN, Marshelle, WESTHEIM, Arne, ZANNAD, Faiez, FLEMING, Thomas, PACKER, Milton, SWEDBERG, Karl, BORER, Jeffrey S, COLUCCI, Wilson S, DJIAN, Jacques, DREXLER, Helmut, FELDMAN, Arthur, KOBER, Lars

“…Studies in experimental models and preliminary clinical experience suggested a possible therapeutic role for the soluble tumor necrosis factor antagonist…”
Get full text

Sacral agenesis and neurogenic bladder: Long-term outcomes of bladder and kidney function by Cho, P.S, Bauer, S.B, Pennison, M, Rosoklija, I, Bellows, A.L, Logvinenko, T, Khoshbin, S, Borer, J.G

“…Summary Background Sacral agenesis (SA) is a rare congenital condition that refers to the absence of part or all of two or more lower sacral vertebral bodies…”
Get full text

Prediction of indications for valve replacement among asymptomatic or minimally symptomatic patients with chronic aortic regurgitation and normal left ventricular performance by BORER, J. S, HOCHREITER, C, ISOM, O. W, HERROLD, E. M, SUPINO, P, ASCHERMANN, M, WENCKER, D, DEVEREUX, R. B, ROMAN, M. J, SZULC, M, KLIGFIELD, P

“…Optimal criteria for valve replacement are unclear in asymptomatic/minimally symptomatic patients with aortic regurgitation (AR) and normal left ventricular…”
Get full text

Control of vascular smooth muscle cell growth by connexin 43 by Joshi, Chintamani N, Martin, Danielle N, Shaver, Patti, Madamanchi, Chaitanya, Muller-Borer, Barbara J, Tulis, David A

“…Connexin 43 (Cx43), the principal gap junction protein in vascular smooth muscle cells (VSMCs), regulates movement of ions and other signaling molecules…”
Get full text

Influence of Dynamic Gap Junction Resistance on Impulse Propagation in Ventricular Myocardium: A Computer Simulation Study by Henriquez, Alexandra P., Vogel, Rolf, Muller-Borer, Barbara J., Henriquez, Craig S., Weingart, Robert, Cascio, Wayne E.

“…The gap junction connecting cardiac myocytes is voltage and time dependent. This simulation study investigated the effects of dynamic gap junctions on both the…”
Get full text

Contemporary approach to aortic and mitral regurgitation by BORER, Jeffrey S, BONOW, Robert O

Get full text

The outcome of voiding dysfunction managed with clean intermittent catheterization in neurologically and anatomically normal children by Pohl, H.G., Bauer, S.B., Borer, J.G., Diamond, D.A., Kelly, M.D., Grant, R., Briscoe, C.J., Doonan, G., Retik, A.B.

“…Objective To describe the tolerability and efficacy of clean intermittent catheterization (CIC) in the management of dysfunctional voiding in patients who are…”
Get full text

Ischemia-induced arrhythmia: the role of connexins, gap junctions, and attendant changes in impulse propagation by Cascio, Wayne E., Yang, Hua, Muller-Borer, Barbara J., Johnson, Timothy A.

“…Sudden cardiac death accounts for more than half of all cardiovascular deaths in the US, and a large proportion of these deaths are attributed to…”
Get full text